Company Filing History:
Years Active: 2020-2025
Title: Shih-Chuan Hsieh: Innovator in Cancer Research
Introduction
Shih-Chuan Hsieh is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer research, particularly in the area of prostate cancer. With a total of 3 patents, Hsieh's work focuses on developing innovative methods and compositions for predicting and treating diseases.
Latest Patents
Hsieh's latest patents include groundbreaking inventions that aim to improve cancer prognosis and treatment. One of his notable patents is related to biomarkers for predicting prostate cancer progression. This invention encompasses biomarkers, methods, and assay kits designed to predict prognosis and monitor the progression of prostate cancer. The biomarkers identified include glycosyltransferases, specifically core 1 beta-3-galactosyltransferase (C1GALT1) and ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3GAL1) gene products, along with their saccharide substrates/products and galectin-4 gene products.
Another significant patent involves the development of a standardized and effect-optimized herbal extract for treating androgen-stimulated disorders. This invention includes a composition featuring a standardized extract and a method for treating such disorders. Hsieh's work in this area also provides a method for qualifying a standardized preparation of the extract for effective treatment.
Career Highlights
Shih-Chuan Hsieh is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work has garnered attention for its potential impact on cancer treatment and patient care. Hsieh's innovative approaches have positioned him as a key figure in the ongoing research efforts aimed at improving cancer prognosis and treatment methodologies.
Collaborations
Hsieh collaborates with esteemed colleagues, including Pei-wen Hsiao and Chin-Hsien Tsai. These partnerships enhance the research efforts and contribute to the advancement of knowledge in the field of cancer research.
Conclusion
Shih-Chuan Hsieh's contributions to cancer research through his patents and collaborations highlight his commitment to innovation in medical science. His work continues to pave the way for advancements in the understanding and treatment of prostate cancer.